PMC:7283670 / 88613-88670 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7283670","sourcedb":"PMC","sourceid":"7283670","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7283670","text":"Experimental: favipiravir combined with tocilizumab group","tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T355","span":{"begin":14,"end":25},"obj":"Chemical"},{"id":"T356","span":{"begin":40,"end":51},"obj":"Chemical"},{"id":"T357","span":{"begin":52,"end":57},"obj":"Chemical"}],"attributes":[{"id":"A355","pred":"chebi_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"id":"A356","pred":"chebi_id","subj":"T356","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A357","pred":"chebi_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"subj":"T355","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T356","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T357","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#ec93a0","default":true}]}]}}